Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iReach: a Novel Medical Device for Early Intervention for Visually Impaired Infants.

NCT06334614 is registered in ClinicalTrials.gov with Istituto Italiano di Tecnologia as lead sponsor.

NCT NCT06334614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06334614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iReach: a Novel Medical Device for Early Intervention for Visually Impaired Infants.
Lead sponsor
Istituto Italiano di Tecnologia
Phase
Not applicable
Overall status
Unknown status
Start date
December 8, 2024
Completion date
December 8, 2025
Enrollment
55 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blindness, visual impairment